Creative Biolabs partners with microbiome innovators who work on Ruminococcus albus, providing end-to-end CRO support from strain isolation and functional characterization to fermentation development and engineered strain optimization, helping teams generate robust, publication-grade and decision-ready data for preclinical microbiome and industrial biotechnology programs.
Biotech and academic groups worldwide choose Creative Biolabs for reliable R. albus microbiome research.
R. albus is a strictly anaerobic, highly cellulose-degrading species that requires precise culturing, isolation, and analytical expertise to generate reproducible data. Its enzymatic machinery—spanning cellulases, hemicellulases, and accessory esterases—plays a central role in plant fiber breakdown, making it a priority organism in microbiome, nutrition, and bioenergy research. Working with an experienced CRO reduces technical variability and ensures high-quality strain recovery and characterization.
As interest grows in R. albus functions across rumen ecosystems, human gut models, metabolic studies, and oxidative-stress–related investigations, a specialized partner like Creative Biolabs provides the controlled workflows, anaerobic infrastructure, and multi-omics capabilities required to de-risk experiments and accelerate meaningful scientific outcomes.
Creative Biolabs establishes robust, strictly anaerobic pipelines to isolate and screen R. albus from rumen, fecal, or synthetic consortia samples. Strains are evaluated for growth, morphology, carbohydrate utilization, and cellulolytic performance, enabling selection of high-value R. albus candidates for downstream applications and mechanistic studies.
Our microbiologists deploy 16S rRNA sequencing, whole-genome sequencing, and targeted qPCR/dPCR panels to accurately identify R. albus in complex microbiome backgrounds. This service confirms strain identity, detects co-colonizing relatives, and supports clear strain tracking in in vitro systems or animal models focused on R. albus.
Leveraging high-content anaerobic fermentation platforms, Creative Biolabs systematically characterizes R. albus carbohydrate fermentative profiles on cellulose, hemicellulose, arabinoxylans, and defined prebiotics. We quantify sugar utilization, short-chain fatty acid output, and gas production, revealing how R. albus deconstructs plant polysaccharides and contributes to butyrate and other metabolites.
Functional screening programs interrogate R. albus enzyme repertoires, signaling potential, and ecosystem roles. Using enzyme assays, omics readouts, and co-culture models, Creative Biolabs maps pathways such as cellulase/xylanase activities, feruloyl esterase functions, and oxidative stress modulation to build mechanism-of-action hypotheses around R. albus behavior.
To understand how R. albus influences host biology, Creative Biolabs develops customized host–microbe interaction assays using intestinal epithelial cells, immune cells, and organoid or gut-on-chip systems. These models capture barrier integrity, cytokine profiles, and oxidative stress parameters in response to live or heat-killed R. albus or its secretome.
Our anaerobic fermentation group designs and scales R. albus fermentation processes from milliliter screening to liter-scale development. We optimize medium composition, pH, redox potential, and gas composition to maximize biomass, enzyme expression, or specific metabolites, providing ready-to-use cell banks, supernatants, or lysates of R. albus for further research.
Creative Biolabs systematically evaluates R. albus stress responses under variations in pH, bile salts, oxygen exposure, temperature, and osmotic pressure. We track viability, transcriptional changes, and functional outputs, enabling rational strategy design for stabilization, formulation, and process robustness of R. albus in vitro and in vivo models.
Using synthetic biology and classical strain improvement, Creative Biolabs offers R. albus probiotics engineering and optimization services. Projects may include enhancing cellulose-degrading capacity, improving oxygen tolerance, tailoring metabolite profiles, or improving encapsulation compatibility, always within research frameworks that respect biosafety and regulatory expectations for R. albus.
Define R. albus goals, matrices, and analytical endpoints with our scientific team.
Process rumen, fecal, or culture samples under strict anaerobic conditions to recover R. albus.
Confirm R. albus identity, characterize genomes, and establish cryopreserved master and working banks.
Implement tailored fermentative, enzymatic, and host–microbe assays to profile R. albus performance.
Develop and refine R. albus fermentation and stabilization parameters for your intended research use.
Deliver structured datasets, interpretive summaries, and recommendations aligned with your R. albus program strategy.
Decades of experience culturing oxygen-sensitive R. albus and related fibrolytic species.
Combine genomics, transcriptomics, metabolomics, and enzymology in one R. albus project.
From exploratory screens to highly standardized platforms, scaled to your R. albus pipeline stage.
Rigorous controls, detailed SOPs, and transparent documentation for robust, repeatable R. albus data.
Microbiologists, bioinformaticians, and formulation scientists collaborating on each R. albus study.
Designed to protect proprietary R. albus strains, constructs, and data packages.
The exceptional cellulolytic and hemicellulolytic enzymes of R. albus support biofuel research by depolymerizing plant biomass into fermentable sugars, informing enzyme cocktails and microbial consortia for ethanol, biogas, and biohydrogen development.
R. albus–derived enzymes such as feruloyl esterases RaFae1A and RaFae1B help uncouple hemicellulose from lignin, enabling release of phenolic compounds and tailor-made bioactives for food, cosmetic, and pharmaceutical ingredient development.
As a dominant fibrolytic rumen bacterium, R. albus is central to fiber degradation in ruminants. Studying its dynamics, enzyme activities, and stress tolerance supports strategies to enhance feed efficiency and nutrient extraction in livestock nutrition models.
R. albus contributes to colonic fiber degradation and short-chain fatty acid formation in humans. Controlled in vitro and ex vivo models can explore how its presence or absence reshapes community composition, metabolite patterns, and markers related to intestinal barrier function.
Preclinical studies report that heat-killed R. albus and its conditioned media can mitigate oxidative stress and β-amyloid–induced neuronal damage, positioning the strain as an intriguing model for gut–brain axis experiments and oxidative stress modulation strategies.
In synthetic microbial ecosystems, R. albus serves as a foundational fibrolytic member, supplying sugars and metabolites to partner strains. Its modular enzyme systems make it an attractive chassis for engineered consortia in biorefining, prebiotic evaluation, and advanced microbiome modeling.
Find the primary product details for the available R. albus strain.
| Product Name | Catalog No. | Target | Product Overview | Size | Price |
|---|---|---|---|---|---|
| Ruminococcus albus; 27210 | LBSX-0522-GF76 | Ruminococcus | Ruminococcus albus was isolated from bovine rumen. | — | Inquiry |
We routinely work with rumen fluid, fecal material from herbivores and humans, bioreactor contents, and synthetic communities. Our team helps design collection, transport, and anaerobic handling strategies optimized for recovering viable R. albus strains from each matrix.
Identification typically combines 16S rRNA gene sequencing with whole-genome analysis and species-specific markers. Where needed, we add phenotypic tests, such as characteristic fiber degradation profiles and enzyme signatures, to confidently classify isolates as R. albus.
Yes. We frequently design side-by-side experiments contrasting R. albus with other rumen or gut fibrolytic species. Standardized culture conditions, assay panels, and multi-omics readouts support robust comparison of enzyme repertoires, metabolite outputs, and stress tolerance.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.